标题
2023 Chinese guideline for lipid management
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 14, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-08-30
DOI
10.3389/fphar.2023.1190934
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Statin Use in Pregnancy: Is It Time For a Paradigm Shift?
- (2022) Rina Mauricio et al. CIRCULATION
- Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels
- (2022) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk
- (2022) Anurag Mehta et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment
- (2022) Paula Byrne et al. JAMA Internal Medicine
- Effects of Cuisine-Based Chinese Heart-Healthy Diet in Lowering Blood Pressure Among Adults in China: Multicenter, Single-Blind, Randomized, Parallel Controlled Feeding Trial
- (2022) Yanfang Wang et al. CIRCULATION
- Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
- (2022) Byeong-Keuk Kim et al. LANCET
- Efficacy and safety of hybutimibe in combination with atorvastatin for treatment of hypercholesteremia among patients with atherosclerotic cardiovascular disease risk equivalent: A multicenter, randomized, double-blinded phase III study
- (2022) Litong Qi et al. Frontiers in Cardiovascular Medicine
- Low-density lipoprotein cholesterol in oldest old with acute myocardial infarction: Is lower the better?
- (2022) Hui-Hui Liu et al. AGE AND AGEING
- Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
- (2022) Michelle L. O’Donoghue et al. CIRCULATION
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
- (2022) Aruna Das Pradhan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of a randomized control trial and an observational biomarker study
- (2022) Yuji Nishizaki et al. AMERICAN HEART JOURNAL
- Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors
- (2021) Kwok Leung Ong et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Fetal toxicity associated with statins: A systematic review and meta-analysis
- (2021) Amir Vahedian-Azimi et al. ATHEROSCLEROSIS
- A systematic review and meta-analysis on the effects of statins on pregnancy outcomes
- (2021) Amir Vahedian-Azimi et al. ATHEROSCLEROSIS
- Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia
- (2021) Moritz Döbert et al. CIRCULATION
- Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement
- (2021) Maria Donata Di Taranto et al. CLINICAL GENETICS
- Triglycerides and Residual Atherosclerotic Risk
- (2021) Sergio Raposeiras-Roubin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacokinetic Study of Oral 14C-Radiolabeled Hyzetimibe, A New Cholesterol Absorption Inhibitor
- (2021) Jianwei Liao et al. Frontiers in Pharmacology
- A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia
- (2021) Maged M. Costantine et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Left ventricular and atrial remodelling in hypertensive patients using thresholds from international guidelines and EMINCA data
- (2021) Yuanyuan Sheng et al. European Heart Journal-Cardiovascular Imaging
- The clinical effect of Xuezhikang combined with ezetimibe in the treatment of coronary heart disease in lipid-lowering treatment and its influence on blood lipid level
- (2021) Liling GUO et al. PANMINERVA MEDICA
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
- (2020) Jan Borén et al. EUROPEAN HEART JOURNAL
- Prognostic value of left ventricular hypertrophy in hypertensive patients: A meta‐analysis of electrocardiographic studies
- (2020) Hongsheng Zhang et al. Journal of Clinical Hypertension
- Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
- (2020) Sotirios Tsimikas et al. NEW ENGLAND JOURNAL OF MEDICINE
- LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial
- (2020) Peter Sever et al. European Journal of Preventive Cardiology
- Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association
- (2020) Laxmi S. Mehta et al. CIRCULATION
- Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease
- (2020) Alan Chait et al. DIABETES
- Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects
- (2020) Jian-Jun Li et al. Expert Opinion on Drug Metabolism & Toxicology
- Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial
- (2020) Rafael Diaz et al. European Journal of Preventive Cardiology
- Evinacumab for Homozygous Familial Hypercholesterolemia
- (2020) Frederick J. Raal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia
- (2020) Gerald F. Watts et al. Heart Lung and Circulation
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2019) Scott M. Grundy et al. CIRCULATION
- Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk
- (2019) Seohyuk Lee et al. European Journal of Preventive Cardiology
- Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
- (2019) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
- (2019) Jane Armitage et al. LANCET
- Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality
- (2019) Victor W. Zhong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomised study of Evolocumab in Patients With Type 2 Diabetes and Dyslipidaemia on Background Statin: Pre-Specified Analysis of the China Population From the BERSON Clinical Trial
- (2019) Yundai Chen et al. DIABETES OBESITY & METABOLISM
- Use of lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. Don P. Wilson, MD, on behalf of the Writing group
- (2019) Don P. Wilson et al. Journal of Clinical Lipidology
- Clinical Practice Recommendations for Pediatric Dyslipidemia
- (2019) Casey Elkins et al. Journal of Pediatric Health Care
- A Novel Modified System of Simplified Chinese Criteria for Familial Hypercholesterolemia (SCCFH)
- (2019) Ye-Xuan Cao et al. Molecular Diagnosis & Therapy
- Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older
- (2019) Richard G. Bach et al. JAMA Cardiology
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
- (2019) Ann C. Skulas-Ray et al. CIRCULATION
- Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75)
- (2019) Yasuyoshi Ouchi et al. CIRCULATION
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
- (2019) Joseph L. Witztum et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of care
- (2019) Uma Ramaswami et al. ATHEROSCLEROSIS
- Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease
- (2019) Anne C. Goldberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ODYSSEY EAST: Alirocumab efficacy and safety vs ezetimibe in high cardiovascular risk patients with hypercholesterolemia and on maximally tolerated statin in China, India, and Thailand
- (2019) Yaling Han et al. Journal of Clinical Lipidology
- 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
- (2019) Ilse K. Luirink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Marine Omega‐3 Supplementation and Cardiovascular Disease: An Updated Meta‐Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants
- (2019) Yang Hu et al. Journal of the American Heart Association
- HEART UK consensus statement on Lipoprotein(a): A call to action
- (2019) Jaimini Cegla et al. ATHEROSCLEROSIS
- Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
- (2018) Christie M. Ballantyne et al. ATHEROSCLEROSIS
- Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial
- (2018) Antonio J. Vallejo-Vaz et al. CIRCULATION
- Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: An Analysis from FOURIER
- (2018) Marc S. Sabatine et al. CIRCULATION
- Role of Anti-PCSK9 Antibodies in the Treatment of Patients with Statin Intolerance
- (2018) Julia Schreml et al. CURRENT MEDICINAL CHEMISTRY
- Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults
- (2018) Mei Zhang et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering
- (2018) Eliano P. Navarese et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Guidance for Pediatric Familial Hypercholesterolemia 2017
- (2018) Mariko Harada-Shiba et al. Journal of Atherosclerosis and Thrombosis
- Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
- (2018) Mariko Harada-Shiba et al. Journal of Atherosclerosis and Thrombosis
- A Meta-Analysis of the Effect of PCSK9-Monoclonal Antibodies on Circulating Lipoprotein (a) Levels
- (2018) Ye-Xuan Cao et al. American Journal of Cardiovascular Drugs
- Familial hypercholesterolemia treatments: Guidelines and new therapies
- (2018) Frederick J. Raal et al. ATHEROSCLEROSIS
- Non-high-density lipoprotein cholesterol and risk of cardiovascular disease in the general population and patients with type 2 diabetes: A systematic review and meta-analysis
- (2018) Yanchao Cao et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation
- (2018) Di Sun et al. Lipids in Health and Disease
- Epidemiology of cardiovascular disease in China: current features and implications
- (2018) Dong Zhao et al. Nature Reviews Cardiology
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liver Transplantation for Homozygous Familial Hypercholesterolemia
- (2018) Yasushi Ishigaki et al. Journal of Atherosclerosis and Thrombosis
- Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study
- (2017) Christian M Madsen et al. EUROPEAN HEART JOURNAL
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
- (2017) Erin A. Bohula et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Zhibitai and low-dose atorvastatin reduce blood lipids and inflammation in patients with coronary artery disease
- (2017) Yuhong Zhao et al. MEDICINE
- Cognitive Function in a Randomized Trial of Evolocumab
- (2017) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
- (2017) Kevin Fitzgerald et al. NEW ENGLAND JOURNAL OF MEDICINE
- A systematic review of the effect of dietary saturated and polyunsaturated fat on heart disease
- (2017) P.M. Clifton et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Efficacy and safety of Zhibitai in combination with atorvastatin for lipid lowering in patients with coronary heart disease
- (2017) Danyan Xu et al. Oncotarget
- Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes
- (2017) Marshall B. Elam et al. JAMA Cardiology
- Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor)
- (2017) Aurélie Thedrez et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- 2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?
- (2016) Sripal Bangalore et al. AMERICAN JOURNAL OF MEDICINE
- The prevalence, awareness, treatment and control of dyslipidemia among adults in China
- (2016) Ling Pan et al. ATHEROSCLEROSIS
- Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese PopulationClinical Perspective
- (2016) Xueli Yang et al. CIRCULATION
- Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association
- (2016) Barbara S. Wiggins et al. CIRCULATION
- Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationClinical Perspective
- (2016) Lotte Kaasenbrood et al. CIRCULATION
- Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular DiseaseCLINICAL PERSPECTIVE
- (2016) Michael J. Blaha et al. CIRCULATION
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- (2016) Børge G. Nordestgaard CIRCULATION RESEARCH
- Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents
- (2016) Paul M Ridker et al. EUROPEAN HEART JOURNAL
- Cardiovascular risk stratification in familial hypercholesterolaemia
- (2016) Mahtab Sharifi et al. HEART
- Efficacy and safety of fenofibrate as an add-on in patients with elevated triglyceride despite receiving statin treatment
- (2016) Shuiping Zhao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
- (2016) Michael G. Silverman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 10-Year Trends in Serum Lipid Levels and Dyslipidemia Among Children and Adolescents From Several Schools in Beijing, China
- (2016) Wenqing Ding et al. JOURNAL OF EPIDEMIOLOGY
- Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment
- (2016) Joseph Yeboah et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
- (2016) Salim Yusuf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
- (2016) Salim Yusuf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
- (2016) Lancet Diabetes & Endocrinology
- IMPROVE-IT clinical implications. Should the “high-intensity cholesterol-lowering therapy” strategy replace the “high-intensity statin therapy”?
- (2015) Luis Masana et al. ATHEROSCLEROSIS
- Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes
- (2015) Antonio J. Vallejo-Vaz et al. ATHEROSCLEROSIS
- Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany
- (2015) Franz Heigl et al. ATHEROSCLEROSIS SUPPLEMENTS
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- High-density lipoprotein subfractions in relation with the severity of coronary artery disease: A Gensini score assessment
- (2015) Rui-Xia Xu et al. Journal of Clinical Lipidology
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
- (2015) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
- (2015) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
- (2015) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
- (2015) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simultaneous determination of hyzetimibe and its main active metabolite in plasma by LC–MS/MS and its application in PK study
- (2015) Jinliang Chen et al. Bioanalysis
- Meta-Analysis of the Effect of Statins on Renal Function
- (2014) Qiang Geng et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials)
- (2014) Daniel Gaudet et al. AMERICAN JOURNAL OF CARDIOLOGY
- The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial
- (2014) Shui-ping Zhao et al. ATHEROSCLEROSIS
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- (2014) M. Cuchel et al. EUROPEAN HEART JOURNAL
- Safety and tolerability of injectable lipid-lowering drugs: a review of available clinical data
- (2014) Arrigo FG Cicero et al. Expert Opinion On Drug Safety
- An assessment by the Statin Liver Safety Task Force: 2014 update
- (2014) Harold Bays et al. Journal of Clinical Lipidology
- An assessment by the Statin Diabetes Safety Task Force: 2014 update
- (2014) Kevin C. Maki et al. Journal of Clinical Lipidology
- Pharmacokinetics, pharmacodynamics, safety, and tolerability of hyzetimibe (HS-25) in healthy Chinese subjects
- (2014) Zhourong Ruan et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)
- (2014) Peter Willeit et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Relations of Change in Plasma Levels of LDL‐C, Non‐HDL‐C and apoB With Risk Reduction From Statin Therapy: A Meta‐Analysis of Randomized Trials
- (2014) George Thanassoulis et al. Journal of the American Heart Association
- Targeting PCSK9 for Hypercholesterolemia
- (2013) Giuseppe Danilo Norata et al. Annual Review of Pharmacology and Toxicology
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia
- (2013) Scott M. Grundy Journal of Clinical Lipidology
- Discovery and refinement of loci associated with lipid levels
- (2013) Cristen J Willer et al. NATURE GENETICS
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials
- (2012) Doralisa Morrone et al. ATHEROSCLEROSIS
- Serum Lipids and Lipoproteins in Chinese Men and Women
- (2012) Wenying Yang et al. CIRCULATION
- Lipid-Related Markers and Cardiovascular Disease Prediction
- (2012) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia
- (2012) Jennifer B. Christian et al. Journal of Clinical Lipidology
- Effects of prescription niacin and omega-3 fatty acids on lipids and vascular function in metabolic syndrome: a randomized controlled trial
- (2012) Gregory C. Shearer et al. JOURNAL OF LIPID RESEARCH
- The Current State of Niacin in Cardiovascular Disease Prevention
- (2012) Paul M. Lavigne et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Similarities and differences between the effects of EPA and DHA on markers of atherosclerosis in human subjects
- (2012) Darshan S. Kelley et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Statin Therapy and the Risk of Intracerebral Hemorrhage
- (2012) James S. McKinney et al. STROKE
- Statins and Intracerebral Hemorrhage
- (2011) Daniel G. Hackam et al. CIRCULATION
- A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
- (2011) Allan D. Sniderman et al.
- Impact of 10mg rosuvastatin daily or alternate-day on lipid profile and inflammatory markers
- (2011) Jian-Jun Li et al. CLINICA CHIMICA ACTA
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Combination of carotid intima-media thickness and plaque for better predicting risk of ischaemic cardiovascular events
- (2011) W. Xie et al. HEART
- Long-Term Probucol Treatment Prevents Secondary Cardiovascular Events: a Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan
- (2011) Shizuya Yamashita et al. Journal of Atherosclerosis and Thrombosis
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
- (2010) SHARP Collaborative Group AMERICAN HEART JOURNAL
- Lipid-Lowering Efficacy of Red Yeast Rice in a Population Intolerant to Statins
- (2010) Carmelo V. Venero et al. AMERICAN JOURNAL OF CARDIOLOGY
- Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)
- (2010) Jian-Jun Li et al. ANNALS OF MEDICINE
- Evaluation of the lipid lowering ability, anti-inflammatory effects and clinical safety of intensive therapy with Zhibitai, a Chinese traditional medicine
- (2010) Dan-yan Xu et al. ATHEROSCLEROSIS
- Future Cardiovascular Disease in China
- (2010) Andrew Moran et al.
- Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
- (2010) Frederick J Raal et al. LANCET
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2010) Dariush Mozaffarian et al. PLOS MEDICINE
- Health effects of trans-fatty acids: experimental and observational evidence
- (2009) D Mozaffarian et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prescription Omega-3 Fatty Acid as an Adjunct to Fenofibrate Therapy in Hypertriglyceridemic Subjects
- (2009) Eli M Roth et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
- (2009) Pierre Amarenco et al. LANCET NEUROLOGY
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction
- (2008) Zongliang Lu et al. AMERICAN JOURNAL OF CARDIOLOGY
- Egg Consumption and Risk of Type 2 Diabetes in Men and Women
- (2008) L. Djousse et al. DIABETES CARE
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now